McLean Hospital at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

McLean Hospital takes part in 3 sessions at CTAD 2026 in Boston. Its program centres on behavioral symptoms and supplements in mild cognitive impairment and dementia. Its work includes a cannabidiol trial for anxiety, nicotinamide riboside target engagement and barriers to inclusive geriatric trials.

OrganizationCTAD 2026 Attendance
McLean Hospital
Belmont, Massachusetts
Hospitals & health systems
Harvard-affiliated psychiatric hospital near Boston, part of Mass General Brigham, with a geriatric psychiatry research programme.
Poster
Thu Nov 19
7:15am–5:00pm

Explore the full CTAD 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full CTAD 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from McLean Hospital

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction